Cancer

Main Content

Cancer Studies

Do you have cancer or related issues? Do you know someone who has similar health interests or issues? UMMC is conducting clinical research studies to look at potential treatments, medications and other cancer-related protocols. If you would like to know more about our efforts, you can visit the links below.

  • This study, referred to as GOG 3015, will evaluate the effect of an experimental drug in patients with newly-diagnosed ovarian, fallopian tube, and /or primary peritoneal cancer. Click here for details.
  • This study, referred to as METIS, is looking at the effectiveness of an experimental device in people with brain tumors as a result of non-small cell lung cancer. Click here for details.
  • This study, referred to as AHOD1721, is looking at how well certain experimental drugs work in children and adolescents with classical Hodgkin’s lymphoma. Click here for details.
  • This study, referred to as GRAVITAS-301, is evaluating the efficacy of an experimental drug in combination with corticosteroids in bone marrow transplant patients with acute graft versus host disease. Click here for details.
  • This study, referred to as AALL1621, is looking at the effects of an experimental drug in pediatric patients with relapsed leukemia. Click here for details.
  • This study, referred to as A LTE15N2, is looking at lab test results and radiology test results to evaluate for long-term effects of high-risk neuroblastoma treatment. Click here for details.
  • The study, referred to as PBMTC, is evaluating the use of next generation sequencing in improving the diagnosis of lower respiratory tract infections in pediatric stem cell transplant patients. Click here for details.
  • This study, referred to as PREAMBLE, is looking at how multiple myeloma is treated by doctors all over the world and how people respond to these treatments. Click here for details.
  • This study, referred to as Pediatric MATCH, is to match participants to targeted experimental drugs based on molecular changes found in their tumor samples. Click here for details.
  • This study, referred to as HEART Study, is looking at whether previous cancer patients who received dexrazoxane have better heart function than those who didn’t receive dexrazoxane. Click here for details.
  • This study, referred to as CHRONOS-4, is looking at the efficacy of an experimental drug in combination with standard immunochemotherapy. Click here for details.
  • This study, referred to as SHERBOC, is evaluating an experimental drug for postmenopausal women whose breast cancer has progressed after prior therapy. Click here for details.
  • This study, referred to as MBC Study, is looking at the safety and tolerability of an experimental drug for women with metastatic or locally advanced recurrent breast cancer. Click here for details.
  • This study, referred to as Niraparib/Bevacizumab Study, is looking at the safety and efficacy of experimental drugs in patients with advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Click here for details.
  • This study, referred to as AIM2CERV, is to determine whether an experimental immunotherapy can reduce the rate of recurrence of cervical cancer in women with high-risk locally advanced disease. Click here for details.